Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunru Lin

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Immunity|May 13, 2025
Sickle cell disease induces chromatin introversion and ferroptosis in CD8<sup>+</sup> T cells to suppress anti-tumor immunityZilong Zhao, Benxia Hu, Yalan Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary CarcinomaKai Yu, Rebecca S Tidwell, Tharakeswara K Bathala, et al.
Nature Communications|April 11, 2024
Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancerJie Fu, Jianhua Ling, Ching-Fei Li, et al.
Science Translational Medicine|November 2, 2022
Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditisYaohua Zhang, Chengcao Sun, Yajuan Li, et al.
Science Advances|February 1, 2023
Tumor-associated nonmyelinating Schwann cell-expressed <i>PVT1</i> promotes pancreatic cancer kynurenine pathway and tumor immune exclusionChengcao Sun, Youqiong Ye, Zhi Tan, et al.
Cell|June 22, 2026
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistanceGuang Lei, Zhengze Lu, Zhihao Xu, et al.
The Journal of Clinical Investigation|June 3, 2025
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer modelsMei-Kuang Chen, Hirohito Yamaguchi, Yuan Gao, et al.
Science (New York, N.Y.)|August 6, 2021
A noncoding RNA modulator potentiates phenylalanine metabolism in miceYajuan Li, Zhi Tan, Yaohua Zhang, et al.
Nature Immunology|June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppressionQingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.
Cancer Discovery|May 13, 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune ArchitectureKai Yu, Jianfeng Chen, Yu-Yi Chu, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Immunity|May 13, 2025
Sickle cell disease induces chromatin introversion and ferroptosis in CD8<sup>+</sup> T cells to suppress anti-tumor immunityZilong Zhao, Benxia Hu, Yalan Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary CarcinomaKai Yu, Rebecca S Tidwell, Tharakeswara K Bathala, et al.
Nature Communications|April 11, 2024
Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancerJie Fu, Jianhua Ling, Ching-Fei Li, et al.
Science Translational Medicine|November 2, 2022
Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditisYaohua Zhang, Chengcao Sun, Yajuan Li, et al.
Science Advances|February 1, 2023
Tumor-associated nonmyelinating Schwann cell-expressed <i>PVT1</i> promotes pancreatic cancer kynurenine pathway and tumor immune exclusionChengcao Sun, Youqiong Ye, Zhi Tan, et al.
Cell|June 22, 2026
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistanceGuang Lei, Zhengze Lu, Zhihao Xu, et al.
The Journal of Clinical Investigation|June 3, 2025
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer modelsMei-Kuang Chen, Hirohito Yamaguchi, Yuan Gao, et al.
Science (New York, N.Y.)|August 6, 2021
A noncoding RNA modulator potentiates phenylalanine metabolism in miceYajuan Li, Zhi Tan, Yaohua Zhang, et al.
Nature Immunology|June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppressionQingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.
Cancer Discovery|May 13, 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune ArchitectureKai Yu, Jianfeng Chen, Yu-Yi Chu, et al.
Pageof 7